Universidad Peruana Cayetano Heredia

Sporotrichosis treatment: Overview and update

Mostrar el registro sencillo del ítem

dc.contributor.author Bustamante Rufino, Ana Beatriz
dc.contributor.author Campos, P.E.
dc.date.accessioned 2022-01-18T19:26:45Z
dc.date.available 2022-01-18T19:26:45Z
dc.date.issued 2011
dc.identifier.uri https://hdl.handle.net/20.500.12866/10836
dc.description.abstract Sporotrichosis, caused by several species from the genus Sporothrix, mainly affects men working in agricultural labor. It is reported mostly from endemic regions located in tropical and subtropical areas. Sporotrichosis usually affects subcutaneous tissue with no symptoms or mild symptoms, but it causes disseminated and even fatal disease if the patient is immunocompromised. Significant progress in the knowledge of etiologic agents of sporotrichosis has been achieved recently, but evaluations of treatment using well-designed clinical trials have been neglected. This article reviews the drugs currently used to treat subcutaneous disease, describing the differences in their efficacy, and reviews recent findings about the proposed new Sporothrix species of clinical interest, as well as the role of melanin as a virulence factor in Sporothrix schenckii. en_US
dc.language.iso eng
dc.publisher Springer
dc.relation.ispartofseries Current Fungal Infection Reports
dc.rights info:eu-repo/semantics/restrictedAccess
dc.rights.uri https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
dc.subject In Vitro Study en_US
dc.subject Review en_US
dc.subject Aminotransferase Blood Level en_US
dc.subject Diarrhea en_US
dc.subject Drug Efficacy en_US
dc.subject Nausea en_US
dc.subject Drug Dose Comparison en_US
dc.subject Posaconazole en_US
dc.subject Treatment Duration en_US
dc.subject Bilirubin Blood Level en_US
dc.subject Drug Safety en_US
dc.subject Pathogenesis en_US
dc.subject Vomiting en_US
dc.subject Antifungal Susceptibility en_US
dc.subject Minimum Inhibitory Concentration en_US
dc.subject Fluconazole en_US
dc.subject Echinocandin en_US
dc.subject Amphotericin B en_US
dc.subject Drug Substitution en_US
dc.subject Drug Withdrawal en_US
dc.subject Amphotericin B Deoxycholate en_US
dc.subject Erythema Nodosum en_US
dc.subject Flu Like Syndrome en_US
dc.subject Flucytosine en_US
dc.subject Fungal Infection en_US
dc.subject Hyperthermic Therapy en_US
dc.subject Itraconazole en_US
dc.subject Ketoconazole en_US
dc.subject Lung Sporotrichosis en_US
dc.subject Melanin en_US
dc.subject Osteoarticular Sporotrichosis en_US
dc.subject Potassium Iodide en_US
dc.subject Ravuconazole en_US
dc.subject Sporothrix Schenckii en_US
dc.subject Sporotrichosis en_US
dc.subject Subcutaneous Sporotrichosis en_US
dc.subject Terbinafine en_US
dc.subject Urticaria en_US
dc.subject Virulence Factor en_US
dc.title Sporotrichosis treatment: Overview and update en_US
dc.type info:eu-repo/semantics/review
dc.identifier.doi https://doi.org/10.1007/s12281-010-0041-7
dc.subject.ocde https://purl.org/pe-repo/ocde/ford#1.06.05
dc.relation.issn 1936-377X


Ficheros en el ítem

Ficheros Tamaño Formato Ver

No hay ficheros asociados a este ítem.

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

info:eu-repo/semantics/restrictedAccess Excepto si se señala otra cosa, la licencia del ítem se describe como info:eu-repo/semantics/restrictedAccess

Buscar en el Repositorio


Listar

Panel de Control

Estadísticas